Product Information
PIRFENIDONE 267 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.8608 per EA under NDC 00904739753. Its NADAC has been published 106 times since Jun 19, 2024.
Strength
267 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904739753
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PIRFENIDONEApproval Type
Generic (ANDA)
FDA Application
ANDA212772On Market Since
5/24/2022
Pharmacological Classes
Price Statistics
The NADAC for PIRFENIDONE 267 MG TABLET has been published 106 times since Jun 19, 2024, and over the history we have for it it has declined 70.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8608 per EA |
|---|---|
| All-time high | $2.9152 (Jul 10, 2024) |
| All-time low | $0.8608 (Jun 17, 2026) |
| 52-week high | $1.5161 |
| 52-week low | $0.8608 |
| Median price | $1.3919 |
| Average price | $1.6399 |
| Largest weekly change | -35.6% (Feb 19, 2025) |
| Weeks tracked | 106 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PIRFENIDONE 267 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PIRFENIDONE 267 MG TABLET, manufactured by Major Pharmaceuticals, is $0.8608 per EA (NDC 00904739753), effective Jun 24, 2026.
How has the price of PIRFENIDONE 267 MG TABLET changed over time?
Over the history we have for it, the NADAC for PIRFENIDONE 267 MG TABLET has declined 70.5%. It has been tracked across 106 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for PIRFENIDONE 267 MG TABLET?
Since Jun 19, 2024, the NADAC for PIRFENIDONE 267 MG TABLET has ranged from a low of $0.8608 (Jun 17, 2026) to a high of $2.9152 (Jul 10, 2024), with a median of $1.3919 per EA.
Are there cheaper alternatives to PIRFENIDONE 267 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as PIRFENIDONE 267 MG TABLET, but none are currently priced below it.
Who manufactures PIRFENIDONE 267 MG TABLET?
PIRFENIDONE 267 MG TABLET (NDC 00904739753) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification